Literature DB >> 20816579

Hereditary genodermatoses with cancer predisposition.

Meg R Gerstenblith1, Alisa M Goldstein, Margaret A Tucker.   

Abstract

In this article hereditary genodermatoses with cancer predisposition are reviewed, including nevoid basal cell carcinoma syndrome, neurofibromatosis types 1 and 2, tuberous sclerosis complex, xeroderma pigmentosum, and dyskeratosis congenita. Hereditary melanoma is also included, though it differs from the others in several respects. The underlying genetic aberrations causing these syndromes are largely known, allowing novel treatments to be developed for some of these disorders. Early recognition and diagnosis allows for close follow-up and surveillance for associated malignancies. Published by Elsevier Inc.

Entities:  

Mesh：

Year:  2010        PMID： 20816579      PMCID： PMC3276063          DOI： 10.1016/j.hoc.2010.06.003

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  184 in total

1.  PTCH mutations in sporadic and Gorlin-syndrome-related odontogenic keratocysts.

Authors:  X-M Gu; H-S Zhao; L-S Sun; T-J Li
Journal:  J Dent Res       Date:  2006-09       Impact factor: 6.116

2.  Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and mice.

Authors:  Jean Y Tang; Michelle Aszterbaum; Mohammad Athar; Franco Barsanti; Carol Cappola; Nini Estevez; Jennifer Hebert; Jimmy Hwang; Yefim Khaimskiy; Arianna Kim; Ying Lu; Po-Lin So; Xiuwei Tang; Michael A Kohn; Charles E McCulloch; Levy Kopelovich; David R Bickers; Ervin H Epstein
Journal:  Cancer Prev Res (Phila)       Date:  2010-01

Review 3.  National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13-15, 1987.

Authors: 
Journal:  Neurofibromatosis       Date:  1988

4.  Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.

Authors:  S L Dabora; S Jozwiak; D N Franz; P S Roberts; A Nieto; J Chung; Y S Choy; M P Reeve; E Thiele; J C Egelhoff; J Kasprzyk-Obara; D Domanska-Pakiela; D J Kwiatkowski
Journal:  Am J Hum Genet       Date:  2000-12-08       Impact factor: 11.025

5.  Skin abnormalities in neurofibromatosis 2.

Authors:  V F Mautner; M Lindenau; M E Baser; L Kluwe; J Gottschalk
Journal:  Arch Dermatol       Date:  1997-12

Review 6.  Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment.

Authors:  Ken Inoki; Kun-Liang Guan
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

7.  Association between cardiac tumors and tuberous sclerosis in the fetus and neonate.

Authors:  Wayne Tworetzky; Doff B McElhinney; Rene Margossian; Anita J Moon-Grady; Denver Sallee; Elizabeth Goldmuntz; Mary E van der Velde; Norman H Silverman; Lindsay D Allan
Journal:  Am J Cardiol       Date:  2003-08-15       Impact factor: 2.778

8.  CDKN2A mutations and melanoma risk in the Icelandic population.

Authors:  A M Goldstein; S N Stacey; J H Olafsson; G F Jonsson; A Helgason; P Sulem; B Sigurgeirsson; K R Benediktsdottir; K Thorisdottir; R Ragnarsson; J Kjartansson; J Kostic; G Masson; K Kristjansson; J R Gulcher; A Kong; U Thorsteinsdottir; T Rafnar; M A Tucker; K Stefansson
Journal:  J Med Genet       Date:  2008-01-04       Impact factor: 6.318

9.  A clinical study of type 2 neurofibromatosis.

Authors:  D G Evans; S M Huson; D Donnai; W Neary; V Blair; V Newton; R Harris
Journal:  Q J Med       Date:  1992-08

Review 10.  Genetics of hair and skin color.

Authors:  Jonathan L Rees
Journal:  Annu Rev Genet       Date:  2003       Impact factor: 16.830
View more
  3 in total

1.  Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy.

Authors:  Jeannette R Wong; Lindsay M Morton; Margaret A Tucker; David H Abramson; Johanna M Seddon; Joshua N Sampson; Ruth A Kleinerman
Journal:  J Clin Oncol       Date:  2014-09-02       Impact factor: 44.544

2.  Fallopian tube correlates of ovarian serous borderline tumors.

Authors:  Anna R Laury; Gang Ning; Charles M Quick; Jonathan Bijron; Mana M Parast; Rebeca A Betensky; Sara O Vargas; Frank D McKeon; Wa Xian; Marisa R Nucci; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2011-12       Impact factor: 6.394

3.  Multiple skin neoplasms in subjects under 40 years of age in Goiania, Brazil.

Authors:  Samir Pereira; Maria Paula Curado; Ana Maria Quinteiro Ribeiro
Journal:  Rev Saude Publica       Date:  2015-10-09       Impact factor: 2.106
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.